List of Menlo Therapeutics patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9968588 Use of NK-1 receptor antagonists in pruritus	Patent 9968588 was granted and assigned to Menlo Therapeutics on May, 2018 by the United States Patent and Trademark Office.		Menlo Therapeutics	United States Patent and Trademark Office	9968588	May 15, 2018
‌ US Patent 10702499 Use of NK-1 receptor antagonists in pruritus		Menlo Therapeutics	Menlo Therapeutics	United States Patent and Trademark Office	10702499	July 7, 2020
‌ US Patent 10278952 Use of NK-1 receptor antagonists in pruritus	Patent 10278952 was granted and assigned to Menlo Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Menlo Therapeutics	Menlo Therapeutics	United States Patent and Trademark Office	10278952	May 7, 2019
‌ US Patent 10617671 Use of NK-1 receptor antagonist serlopitant in pruritus	Patent 10617671 was granted and assigned to Menlo Therapeutics on April, 2020 by the United States Patent and Trademark Office.	Menlo Therapeutics	Menlo Therapeutics	United States Patent and Trademark Office	10617671	April 14, 2020
‌ US Patent 9974769 Use of NK-1 receptor antagonist serlopitant in pruritus	Patent 9974769 was granted and assigned to Menlo Therapeutics on May, 2018 by the United States Patent and Trademark Office.		Menlo Therapeutics	United States Patent and Trademark Office	9974769	May 22, 2018